NLS Pharmaceutics Submits 3 Abstracts for 2025 ASCP Meeting
NLS Pharmaceutics Ltd, a Swiss clinical-stage biopharmaceutical company focused on developing innovative therapies for central nervous system (CNS) disorders, is pleased to announce the submission of three research abstracts...